Literature DB >> 25178938

SLC19A1 hot spot for MTX plasma concentration.

Angela Gutierrez-Camino1, Elixabet Lopez-Lopez, Africa Garcia-Orad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25178938     DOI： 10.1007/s12032-014-0204-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  2 in total

1.  Effects of a microRNA binding site polymorphism in SLC19A1 on methotrexate concentrations in Chinese children with acute lymphoblastic leukemia.

Authors:  Shu-mei Wang; Lu-lu Sun; Wei-xin Zeng; Wan-shui Wu; Guo-liang Zhang
Journal:  Med Oncol       Date:  2014-06-14       Impact factor: 3.064

2.  Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia.

Authors:  Elixabet Lopez-Lopez; Javier Ballesteros; Maria A Piñan; José Sanchez de Toledo; Nagore Garcia de Andoin; Purificacion Garcia-Miguel; Aurora Navajas; Africa Garcia-Orad
Journal:  Pharmacogenet Genomics       Date:  2013-02       Impact factor: 2.089
  2 in total
  2 in total

Review 1.  The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.

Authors:  Shoshana Rudin; Marcus Marable; R Stephanie Huang
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-04-06       Impact factor: 7.691

Review 2.  MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy.

Authors:  Maitane Umerez; Ángela Gutierrez-Camino; Carmen Muñoz-Maldonado; Idoia Martin-Guerrero; Africa Garcia-Orad
Journal:  Pharmgenomics Pers Med       Date:  2017-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.